000 01540 a2200421 4500
005 20250516054427.0
264 0 _c20120309
008 201203s 0 0 eng d
022 _a1941-837X
024 7 _a10.3111/13696998.2011.618517
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOleen-Burkey, M A
245 0 0 _aThe relationship between alternative medication possession ratio thresholds and outcomes: evidence from the use of glatiramer acetate.
_h[electronic resource]
260 _bJournal of medical economics
_c2011
300 _a739-47 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aCosts and Cost Analysis
650 0 4 _aDrug Utilization
650 0 4 _aFees, Pharmaceutical
_xstatistics & numerical data
650 0 4 _aFemale
650 0 4 _aGlatiramer Acetate
650 0 4 _aHealth Services
_xeconomics
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Sclerosis, Relapsing-Remitting
_xdrug therapy
650 0 4 _aPeptides
_xadministration & dosage
650 0 4 _aRecurrence
650 0 4 _aRetrospective Studies
650 0 4 _aAssessment of Medication Adherence
700 1 _aDor, A
700 1 _aCastelli-Haley, J
700 1 _aLage, M J
773 0 _tJournal of medical economics
_gvol. 14
_gno. 6
_gp. 739-47
856 4 0 _uhttps://doi.org/10.3111/13696998.2011.618517
_zAvailable from publisher's website
999 _c21153514
_d21153514